Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Steroid-sensitive nephrotic syndrome (SSNS) is a kidney disease defined by selective proteinuria, hypoalbuminaemia and, on renal biopsy, minimal changes without immunoglobulin deposits.
Biomarker and diagnostic research for idiopathic steroid-sensitive nephrotic syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for idiopathic steroid-sensitive nephrotic syndrome.
3 publications have been identified in PubMed for idiopathic steroid-sensitive nephrotic syndrome. Research spans Diagnostic / Biomarker (33%), Clinical Trial Publication (33%), and Basic Science / Preclinical (33%).
Benz MR (2026). [PMID: 41856160](https://pubmed.ncbi.nlm.nih.gov/41856160/). *Lancet Child Adolesc Health*. [Clinical Trial Publication]
Chaudhary AK (2026). [PMID: 41259273](https://pubmed.ncbi.nlm.nih.gov/41259273/). *J Bras Nefrol*. [Diagnostic / Biomarker]
Kanai T (2025). [PMID: 41439970](https://pubmed.ncbi.nlm.nih.gov/41439970/). *Cells*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:09 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center